Structure |
Chemical Name |
CAS |
MF |
|
N-(2-Chloropyrimidin-4-YL)-2,3-dimethyl-2H-indazol-6-amine |
444731-74-2 |
C13H12ClN5 |
|
Vonoprazan fumarate |
1260141-27-2 |
C21H20FN3O6S |
|
6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
1016636-76-2 |
C13H13BrClN3O |
|
Trelagliptin succinate |
1029877-94-8 |
C22H26FN5O6 |
|
5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester |
70374-38-8 |
C10H12ClNO6S2 |
|
2,2',7,7'-Tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene |
207739-72-8 |
C81H68N4O8 |
|
1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE |
18048-64-1 |
C12H14N2O |
|
(6R,S)-5,6,7,8-TETRAHYDRO-L-BIOPTERIN DIHYDROCHLORIDE |
62989-33-7 |
C9H15N5O3 |
|
ledipasvir interMediate |
1441673-92-2 |
C12H20KNO4 |
|
4-Benzofurancarboxylic Acid |
166599-84-4 |
C9H6O3 |
|
Methyl 5-chloro-3-chlorosulfonyl-2-thiophene carboxylate |
70374-37-7 |
C7H8ClNO4S2 |
|
2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid |
70785-61-4 |
C15H14N2O5 |
|
2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one |
277299-70-4 |
C12H14N2O |
|
3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine |
134002-25-8 |
C18H20N2O |
|
(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
477600-70-7 |
C14H22N2 |
|
2'-Bromo-2'-deoxyuridine |
72218-68-9 |
C9H11BrN2O5 |
|
Itraconzole intermediate |
|
|
|
(2R,3R,4R,5R)-4-(Acetyloxy)-2-(5-fluoro-4-formamido-2-oxo-1,2-dihydropyrimidin-1-yl)-5-methyloxolan-3-yl acetate |
|
|
|
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
|
(R)-Levofloxacin |
|
C18H20FN3O4 |
|
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) |
906093-30-9 |
C16H22N4O2 |
|
1-Methyl-3-pyrrolidinol |
13220-33-2 |
C5H11NO |
|
5,6,12,13-tetrabromo-Perylo[3,4-cd:9,10-c'd']dipyran-1,3,8,10-tetrone |
321945-85-1 |
C24H4Br4O6 |
|
Ofloxacin EP Impurity C |
95848-94-5 |
C18H21N3O4 |
|
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate |
1034975-62-6 |
C21H25F6N3O6 |
|
Posaconazole Diastereoisomer 11 |
171228-50-5 |
C37H42F2N8O4 |
|
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
941688-05-7 |
C17H18N6 |
|
Eribulin intermediate |
157322-47-9 |
C21H35IO4 |
|
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester |
1428243-26-8 |
C16H20BrNO3 |
|
tiotropium bromide hydrate |
411207-31-3 |
C19H24BrNO5S2 |
|
Azacitidine Impurity 3 |
157771-77-2 |
C8H12N4O5 |
|
Lumacaftor Intermediate |
936727-68-3 |
C17H13ClF2N2O3 |
|
3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene |
54690-63-0 |
C24H35NO3Si |
|
Dehydronandrolone Acetate |
2590-41-2 |
C20H26O3 |
|
(4-bromo-2-fluorophenyl)-(3,4,5-trimethoxyphenyl)methanone |
1016544-26-5 |
C16H14BrFO4 |
|
16,16-DIMETHYL PROSTAGLANDIN E2 |
39746-25-3 |
C22H36O5 |
|
9-Phenylacridine |
602-56-2 |
C19H13N |
|
6R,7S-Ceftazidime isomer |
|
|
|
Oseltamivir Fructose Adduct 2 |
|
|
|
Sugammadex sodium Pentabromide intermediate |
|
|
|
(3S,5S,2S,3R)-posaconazole |
|
|
|
tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate |
1350636-75-7 |
C11H21NO3S |
|
Isopropyl creatinine |
|
C7H13N3O |
|
2-(4-NITROPHENYL)BUTYRIC ACID |
7463-53-8 |
C10H11NO4 |
|
(+ -) H3RESCA-TFA |
1919794-40-3 |
C27H28F4N2O8 |
|
Ceftiofur Double Side Chain |
|
|
|
Flomoxef Intermediate F3-01 |
|
|
|
5-Pyrimidineacetamide, 2-butyl-1-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-1,6-dihydro-N,N,4-trimethyl-6-oxo- |
1985668-78-7 |
C27H30N4O2 |
|
2',3'-Dideoxy-2',3'-didehydroinosine |
42867-68-5 |
C10H10N4O3 |
|
Cephalosporin |
11111-12-9 |
C16H21N3O8S |
|
3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-one |
15462-91-6 |
C22H26O6 |
|
potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate |
5991-71-9 |
C16H10ClKN2O3 |
|
hexahydro-1-methyl-3-(3-oxo-1-cyclohexen-1-yl)-2H-azepin-2-one |
71556-70-2 |
C13H19NO2 |
|
alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylphenethyl alcohol |
73404-00-9 |
C26H31NO2 |
|
4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester |
123864-17-5 |
C38H42O10 |
|
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine |
314771-76-1 |
C18H16ClFN4O2 |
|
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
|
3-(4-Phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine |
330786-24-8 |
C17H13N5O |
|
Cabazitaxel N-3 |
859498-31-0 |
C57H61Cl6NO19 |
|
Micafungin FR-179642 impurity (acid) |
168110-44-9 |
C35H52N8O20S |
|
Bis(4-isopropylphenyl)iodonium chloride |
97671-66-4 |
C18H22ClI |
|
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
|
Coumarin |
10172-75-5 |
C26H18O7 |
|
PROSTAGLANDIN H2 |
42935-17-1 |
C20H32O5 |
|
2,4-dihydroxy-6-propyl-benzoic acid methyl ester |
55382-52-0 |
C11H14O4 |
|
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
|
1-Vinylimidazole |
1072-63-5 |
C5H6N2 |
|
2'-CHLORO-2'-DEOXYURIDINE |
4753-04-2 |
C9H11ClN2O5 |
|
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN F2ALPHA |
27376-76-7 |
C20H34O5 |
|
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
|
(3S,4R,5R)-Oseltamivir |
|
|
|
4-Benzo[b]thien-2-ylbenzenamine |
54492-95-4 |
C14H11NS |
|
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-(6-fluoro-3-pyridinyl)-6-hydroxy- |
2222654-09-1 |
C13H7FN4O |
|
1-chloro-8-phenyl-Dibenzofuran |
2379717-75-4 |
C18H11ClO |
|
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
|
Isopropyl 2-((5-amino-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)amino)-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate |
1847465-25-1 |
C29H37N7O3 |
|
7-amino-3-phenyl-2-benzopyrone |
4108-61-6 |
C15H11NO2 |
|
methyl ibogamine-18-carboxylate |
467-77-6 |
C21H26N2O2 |
|
4-Methylcumarin |
607-71-6 |
C10H8O2 |
|
Dabigatran intermediate |
|
|
|
INTERMEDIATES |
1243021-74-0 |
C13H26N2O5 |
|
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
|
2'-DEOXYCYTIDINE MONOHYDRATE, 99+% |
652157-52-3 |
C9H15N3O5 |
|
tert-butyl (3R,6S)-3-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino) -6-carbamoyl -5-methyl-3,6-dihydropyridine-1(2H)-carboxylate |
2209874-00-8 |
C23H43N3O6Si |
|
Silicone intermediate |
|
|
|
7-Chloro-1H-pyrrolo[3,2-b]pyridine |
357263-48-0 |
C7H5ClN2 |
|
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
|
4-AMINO-CHROMEN-2-ONE |
53348-92-8 |
C9H7NO2 |
|
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
|
S-(+)-Methoprene |
65733-16-6 |
C19H34O3 |
|
PROSTAGLANDIN A2 |
13345-50-1 |
C20H30O4 |
|
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
|
tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
866084-31-3 |
C33H45N7O4 |
|
(7alpha,17beta)-17-(Acetyloxy)-7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]estr-4-en-3-one |
415927-29-6 |
C34H51F5O3S |
|
5-Bromo-2-methylbenzoic acid |
79669-49-1 |
C8H7BrO2 |
|
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
|
2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine |
1269440-58-5 |
C10H10ClIN4 |
|
Coumarin |
15938-72-4 |
C28H22O9 |